ALK
ALK is engaged in the research and development of allergy immunotherapy products for the prevention and treatment of allergy.
Business Model:
Revenue: $610.1M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed ALK Information
Geographic Data
Address: Bøge Allé 6-8
City: Hørsholm
State: other
Zip: 2970
Country: DK
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
10,617,155Website Global Rank
53Website Monthly Traffic
Twitter Followers
Description
ALK is engaged in the research and development of allergy immunotherapy products for the prevention and treatment of allergy.
Contact Phone:
Contact Email:
ALK went public on 6/28/2002 on the Nasdaq OMX Nordic
Listed Exchange:
Nasdaq OMX Nordic
IPO Date:
6/28/2002
Ticker Symbol:
ALK B
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2011 | DBV Technologies | Series C | 25.5M |
| 1/2009 | DBV Technologies | Series B | 7.8M |
| 1/2011 | DBV Technologies | Series C | 0 |
| 1/2009 | DBV Technologies | Series B | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2014 | Bio‐Medical Services | |
| 5/2005 | Allerbio |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
